Results 161 to 170 of about 41,795 (272)

T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Ovarian cancer remains a formidable therapeutic challenge due to late diagnosis, high recurrence rates, and limited treatment options. Mesothelin (MSLN) is highly expressed in ovarian cancer, making it a promising target for immunotherapy.
Yiyang Shan   +7 more
wiley   +1 more source

[Probable neutropenia secondary to treatment with rifampicin]. [PDF]

open access: yesRev Esp Quimioter
España-Marí G   +4 more
europepmc   +1 more source

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial

open access: yesClinical and Translational Discovery, Volume 6, Issue 1, February 2026.
Abstract Objective To explore the efficacy and safety of surufatinib in combination with anti‐PD‐1/PD‐L1 antibodies (with or without chemotherapy) in patients with advanced BTC after failure of first‐line treatment. Methods 24 patients with advanced BTC who failed first‐line treatment were admitted to our centre from March 2023 to August 2024 and ...
Xinni Chen   +7 more
wiley   +1 more source

Ulceration in Dermatophyte Infection in Methotrexate Toxicity: Hitherto Unkown. [PDF]

open access: yesIndian Dermatol Online J
Das P   +5 more
europepmc   +1 more source

Experience of the University of Pittsburgh, Pittsburgh, Pennsylvnaia, USA [PDF]

open access: yes, 1989
Carroll, PB   +4 more
core  

Frontiers in the Management of Orthopaedic Periprosthetic Joint Infection

open access: yesJournal of Orthopaedic Research, Volume 44, Issue 2, February 2026.
ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty (TJA), one of the most frequently performed surgical procedures worldwide. Management of acute PJI commonly involves debridement, antibiotics, and implant retention (DAIR), though failure rates remain high due to antibiotic‐tolerant biofilms. Chronic
Michael F. Shannon   +9 more
wiley   +1 more source

Methotrexate toxicity and intolerance in paediatric inflammatory bowel disease: A retrospective cohort study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 477-486, February 2026.
Abstract Objectives Methotrexate (MTX) is frequently prescribed in paediatric inflammatory bowel disease (IBD), with routine laboratory monitoring to detect adverse events (AEs), such as hepatotoxicity and myelotoxicity. However, data on the incidence and predictors of these AEs remain limited.
Eva Vermeer   +7 more
wiley   +1 more source

Long-Term Therapeutic Outcomes with Cladribine in Patients with Xanthoma Disseminatum. [PDF]

open access: yesIndian Dermatol Online J
Sharma A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy